Targacept to Present at the Cowen and Company 34th Annual Health Care Conference

[Business Wire] – Targacept, Inc. , a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th An more

View todays social media effects on TRGT

View the latest stocks trending across Twitter. Click to view dashboard

See who Targacept is hiring next, click here to view